Clinical Trials Directory

Trials / Unknown

UnknownNCT03693885

Oxytocin Administration Prior Planned Caesarean Section

Mild Induced Labour Prior to Planned Caesarean Delivery to Improve Neonatal and Maternal Outcome - a Randomized Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,450 (estimated)
Sponsor
University of Zurich · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Spontaneous vaginal delivery of a healthy infant provokes a unique surge in stress hormone concentrations (e.g. AVP (arginine vasopressin) /copeptin) incommensurable with child or adult levels measured in any other situation. In contrast, infants delivered by primary caesarean section without preceding labour have low stress hormone concentrations at birth unless other stressors are present, including chorioamnionitis or intrauterine growth restriction. Infants delivered by caesarean section after a trial of labour show copeptin concentrations between these two extremes. Objectives:1) To reduce neonatal respiratory morbidity and admission to the Neonatal Intensive Care Unit and increase bonding and breastfeeding by triggering uterine contractions prior to planned caesarean delivery. 2\) To collect prospectively weight data of infants in the first 6 months of life to validate and expand our online neonatal weight calculator. Study design: Open label; randomised, placebo controlled trail Intervention: Oxytocin challenge test (OCT): Infusion of oxytocin 5 IU/500 ml Ringer® lactate at a rate of 12 ml/h and doubled every 10 min until three uterine contractions per 10-min interval are induced, at which point it will be stopped. Primary endpoint: \- Incidence of neonatal respiratory morbidity Secondary endpoints: * Umbilical cord blood copeptin levels * Postnatal neonatal weight change * Breastfeeding status

Conditions

Interventions

TypeNameDescription
OTHEROxytocin challenge test (OCT)Infusion of oxytocin 5 IU/500 ml Ringer® lactate at a rate of 12 ml/h and doubled every 10 min until three uterine contractions per 10-min interval are induced, at which point it will be stopped.

Timeline

Start date
2019-01-01
Primary completion
2024-12-31
Completion
2025-06-01
First posted
2018-10-03
Last updated
2023-10-31

Locations

5 sites across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03693885. Inclusion in this directory is not an endorsement.